Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
GPCR
#1534
Structure Therapeutics Inc. American Depositary Shares
54.250
0
USD
+1.94%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.94%
Aylık Değişim
-3.56%
6 aylık değişim
+102.88%
Yıllık Değişim
+102.88%
Önceki Kapanış
53.220
0
Open
54.250
0
Bid
Ask
Low
54.250
0
High
54.250
0
Hacim
82
Piyasalar
ABD Borsası
Sağlık Hizmetleri
GPCR
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
57.34 M
57.54 M
57.6 M
60.68 M
70.84 M
—
Valuation ratios
Enterprise value
1.39 B
843.84 M
1.05 B
1.6 B
4.13 B
7.61 B
Price to earnings ratio
-34.77
-19.9
-19.75
-22.95
-86.94
-149.54
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-36.72
-20.92
-21.47
-24.53
-55.59
-122.51
Price to book ratio
4.95
0.8
1.04
1.46
8.15
11.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.04
-0.05
-0.08
-0.08
0.02
-0.19
Return on equity %
-0.04
-0.06
-0.08
-0.09
0.02
-0.2
Return on invested capital %
-790.46
-750.87
-792.18
-766.76
131.56
-2 178.26
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.74
23.29
20.48
14.15
24.81
82.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.23
-0.3
-0.32
-0.29
-0.36
-1.27
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.59
4.86
4.56
4.55
8.14
22.12
Net current asset value per share
5.64
4.94
4.64
4.64
8.84
23.06
Tangible book value per share
5.48
4.79
4.48
4.39
8.54
22.2
Working capital per share
5.42
4.73
4.41
4.31
8.49
21.93
Book value per share
5.48
4.79
4.48
4.39
8.54
22.2
Haberler
Structure Therapeutics hisseleri için Leerink tavsiyesi Outperform
Structure Therapeutics, Matthew Lang’ı COO ve hukuk müşaviri seçti
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy
Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)
Wolfe Research, Structure Therapeutics hissesine Peerperform notu verdi
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial
Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?
BMO raises Structure Therapeutics stock price target on obesity drug data
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)
H.C. Wainwright, Structure Therapeutics için hedef fiyatı düşürdü